ClinicalTrials HQ

Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)

Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)

Active, not recruiting · NCT03850964 · Registry updated 2026-03-19
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epistaxis, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, anemia, cardiovascular disorder, hematologic disorder, hemorrhagic disease, hereditary hemorrhagic telangiectasia, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, telangiectasis, vascular disorder, vascular hemostatic disease, vascular malformationActive, not recruitingPhase 2 / Phase 32026-03-19NCT03850964

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Cure HHT3

11 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Augusta UniversityAugustaUnited States57
Cleveland ClinicClevelandUnited States558
John Hopkins UniversityBaltimoreUnited States14
Massachusetts General HospitalBostonUnited States1015
Mayo ClinicRochesterUnited States664
University of California - Los AngelesLos AngelesUnited States6
University of ColoradoDenverUnited States14
University of North CarolinaChapel HillUnited States38
University of Texas - SouthwesternDallasUnited States2
University of Utah Medical CenterSalt Lake CityUnited States5
Washington UniversitySt LouisUnited States182